These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25983302)

  • 1. [Glycated albumin as a marker of glycemia in diabetes and its vascular complications].
    Warwas M; Żurawska-Płaksej E; Ciężka D; Piwowar A
    Postepy Hig Med Dosw (Online); 2015 May; 69():638-48. PubMed ID: 25983302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated albumin in diabetic patients with chronic kidney disease.
    Zheng CM; Ma WY; Wu CC; Lu KC
    Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
    Sato A
    Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.
    Yazdanpanah S; Rabiee M; Tahriri M; Abdolrahim M; Rajab A; Jazayeri HE; Tayebi L
    Crit Rev Clin Lab Sci; 2017 Jun; 54(4):219-232. PubMed ID: 28393586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.
    Gan T; Liao B; Xu G
    J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,5-Anhydroglucitol and glycated albumin in glycemia.
    Koga M
    Adv Clin Chem; 2014; 64():269-301. PubMed ID: 24938022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent topics in chemical and clinical research on glycated albumin.
    Ueda Y; Matsumoto H
    J Diabetes Sci Technol; 2015 Mar; 9(2):177-82. PubMed ID: 25614014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of poor glycemic control and the monitoring utility of glycated albumin among diabetic patients attending clinic in tertiary hospitals in Dodoma, Tanzania: A cross-sectional study protocol.
    Mkumbi GG; Boaz M
    PLoS One; 2024; 19(9):e0289388. PubMed ID: 39231139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated albumin; clinical usefulness.
    Koga M
    Clin Chim Acta; 2014 Jun; 433():96-104. PubMed ID: 24631132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control.
    Takahashi S; Uchino H; Shimizu T; Kanazawa A; Tamura Y; Sakai K; Watada H; Hirose T; Kawamori R; Tanaka Y
    Endocr J; 2007 Feb; 54(1):139-44. PubMed ID: 17159300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated albumin: a potential biomarker in diabetes.
    Freitas PAC; Ehlert LR; Camargo JL
    Arch Endocrinol Metab; 2017; 61(3):296-304. PubMed ID: 28699985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of glycated albumin as another glycemic control marker.
    Koga M; Kasayama S
    Endocr J; 2010; 57(9):751-62. PubMed ID: 20724796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin.
    Kisugi R; Kouzuma T; Yamamoto T; Akizuki S; Miyamoto H; Someya Y; Yokoyama J; Abe I; Hirai N; Ohnishi A
    Clin Chim Acta; 2007 Jul; 382(1-2):59-64. PubMed ID: 17482589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated albumin as biomarker: Evidence and its outcomes.
    Kohzuma T; Tao X; Koga M
    J Diabetes Complications; 2021 Nov; 35(11):108040. PubMed ID: 34507877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of serum glycated albumin and high sensitivity C - reactive protein in the insight of cardiovascular complications in diabetic chronic kidney disease patients.
    Vijayaraghavan B; Padmanabhan G; Ramanathan K
    Afr Health Sci; 2020 Mar; 20(1):308-313. PubMed ID: 33402919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.